Amgen Inc. buy Argus
Start price
17.10.23
/
50%
€269.00
Target price
17.10.24
€293.01
Performance (%)
9.94%
End price
18.10.24
€295.75
Summary
This prediction ended on 18.10.24 with a price of €295.75. The BUY prediction by Argus finished with a performance of 9.94%. Argus has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. A total of €8.16 was paid as dividends for this prediction. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -1.185% | -1.185% | 8.681% |
| iShares Core DAX® | 1,93 % | -2,11 % | 11,14 % |
| iShares Nasdaq 100 | -0,18 % | -5,90 % | -0,15 % |
| iShares Nikkei 225® | 7,08 % | 6,46 % | 28,83 % |
| iShares S&P 500 | -0,20 % | -3,67 % | -0,10 % |
Comments by Argus for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Argus from $280.00 to $310.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Argus gewählte maximale Laufzeit wurde überschritten